Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes - Test2 - elhamkhani - TriplyDB

Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes

Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes

http://www.wikidata.org/entity/Q27478075

about

Dengue Fever: Causes, Complications, and Vaccine Strategies Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines.Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.Next-generation dengue vaccines: novel strategies currently under development.An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice.A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.

P2860

Q26700082-B5304C02-26D3-40DB-86BD-38FC0F40B75B Q27013568-CF1E61CC-B75E-4313-808D-65AD26A11CC3 Q27481420-E0D202A8-9D34-4396-8D92-48D2714C289C Q27481478-B56529C3-9DFF-42E1-BD6C-90D070568734 Q27485491-5ACD73ED-7B89-45C5-B31B-C012A78DCE9B Q27486406-10178413-F278-4D06-A67D-D64CAF5F1F26 Q30427591-81F2A94E-B480-45A6-9F73-93DC64030D4E Q33699057-16A839B3-2A86-42E9-816A-9DDAA71DEC82 Q34202440-6190976C-01AB-45D3-B89B-F4A7FF222DEE Q35491639-FD848F5B-97E7-4766-9891-250CEA3C11D1 Q36667964-958A1340-507D-4324-BB7D-099D8C811068 Q37120117-0541E3F7-CE04-4504-B73C-FB60B8607FF1 Q37694855-14F5B539-3C1A-476F-8843-FF1266899B2A Q40379142-B62B2BF8-EB76-418D-AFDB-4BDBC7333390

P2860

Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes

http://www.wikidata.org/entity/Q27478075

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@ast

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@en

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@nl

type

label

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@ast

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@en

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@nl

prefLabel

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@ast

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@en

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@nl

P1433

Q27478075-E89099B4-66F8-4668-9D90-76A755DCACDC

P1476

Q27478075-DB5C1FFD-229D-42D1-BEEF-09DD757DA2A2

P2093

Q27478075-159C3B8A-38B7-4806-8199-71A3A9A660AF

Q27478075-2E89BB58-99FC-4588-81FC-A18C783AFBE1

Q27478075-4C849849-4A67-4F9F-9331-C56271BE8C5E

Q27478075-61684380-5F40-4999-BFB3-EAFAE0CC53E5

Q27478075-655C947B-CE14-4FA1-B32D-603577256DFF

Q27478075-7E6151F8-235F-4CF6-8BE3-3C0AD94CB2DA

Q27478075-A66C884C-9CC6-408A-A2AE-F7F71A40E0DD

Q27478075-BF48A57D-D4CA-4024-8603-6DA8C63BB3DC

P2860

Q27478075-0E8F2279-8CF3-4476-AEE1-A8C117629D73

Q27478075-162A6113-93E6-4138-879F-391C508C97A5

Q27478075-182145E2-F326-4FA4-BBBA-30CD6388869B

Q27478075-2519E8F5-52FE-436D-A4E9-B6B073678EC3

Q27478075-2F0173D1-9F05-4684-A488-B29961F18ACF

Q27478075-32BEB7D2-74AC-44E6-9CD2-9BC31FC7BAD1

Q27478075-44811930-2EF5-4B75-8223-3E5933F26F5E

Q27478075-59CEBEA3-12F7-4909-937A-D1EE667B3267

Q27478075-5BEA1C30-2016-4CA5-B3DD-227B26690C5E

Q27478075-60E55561-F67A-4CFF-BDB1-A1A6F3934E50

P304

Q27478075-9F0AD851-FB64-4CC1-A92E-C08E40EE6D16

P31

Q27478075-3E22E5DE-3E83-47F2-86D8-08FD37E621A3

P3181

Q27478075-850C4EAD-F679-41CF-AE76-F5124DF232DD

P356

Q27478075-9C22480F-9703-45C9-8E36-3D0F49887BAF

P433

Q27478075-5890BF16-F779-46C3-BCC0-11E89B9E63A8

P478

Q27478075-EB5C2217-2410-481F-8B84-448466A38D37

P577

Q27478075-7B045823-FB7D-47C5-A5A1-615B5907B356

P698

Q27478075-E6D2C649-B527-4FB8-AF1E-2A5B3CD805FC

P921

Q27478075-5A76B06C-9026-4647-B8F0-A5E90A24FBE1

Q27478075-B0D7B87A-5A84-46B8-97E8-7F4E7272ABFE

Q27478075-D4C2D5C6-4C97-4CA1-B0C2-545858B15B53

P932

Q27478075-49C4452D-D678-4B0F-B815-7069236D5819

P3181

P356

P1433

Clinical and Vaccine Immunology

P1476

Two Complex, Adenovirus-Based ...... ll Four Dengue Virus Serotypes

@en

P2093

Danher Wang

http://www.w3.org/2001/XMLSchema#string

David H Holman

http://www.w3.org/2001/XMLSchema#string

Jianghui Zhang

http://www.w3.org/2001/XMLSchema#string

John Y Dong

http://www.w3.org/2001/XMLSchema#string

Kanakatte Raviprakash

http://www.w3.org/2001/XMLSchema#string

Kevin R Porter

http://www.w3.org/2001/XMLSchema#string

Min Luo

http://www.w3.org/2001/XMLSchema#string

Nicholas U Raja

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue and dengue hemorrhagic fever

The dengue viruses

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model

Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form

Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones

P304

182-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4470375

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/CVI.00330-06

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17192403

http://www.w3.org/2001/XMLSchema#string

P921

clinical chemistry

P932

1797786

http://www.w3.org/2001/XMLSchema#string